These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6665858)

  • 21. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.
    Roselaar SE; Schonfeld G; Daugherty A
    J Clin Invest; 1995 Sep; 96(3):1389-94. PubMed ID: 7657813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of cyclosporin--A-induced graft acceptance.
    White DJ; Timmerman W; Davies HS; Nagao T; Kasahara K; Plumb A
    Transplant Proc; 1981 Mar; 13(1 Pt 1):379-82. PubMed ID: 7022857
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiovascular system transplantation. 7-2. Immunological effects of cyclosporine on canine ectopic heart transplantation].
    Mizuochi I; Suzuki S; Amemiya H
    Nihon Rinsho; 1985 Jul; 43(7):1513-6. PubMed ID: 2932571
    [No Abstract]   [Full Text] [Related]  

  • 25. The First International Congress on Cyclosporine. May 16-19, 1983, Houston, Texas.
    Transplant Proc; 1983 Dec; 15(4 Suppl 1-2):2207-3187. PubMed ID: 6665857
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of cyclosporin in renal transplantation].
    Lang P; Buisson C
    Presse Med; 1987 Sep; 16(29):1398-400. PubMed ID: 2958793
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolongation of canine pancreas allografts with cyclosporin A.
    McMaster P; Procyshyn A; Calne RY; Valdes R; Rolles K; Smith D
    Transplant Proc; 1980 Jun; 12(2):275-7. PubMed ID: 6771904
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac allograft survival in cynomolgus monkeys treated with cyclosporin-A in combination with conventional immune suppression.
    Pennock JL; Reitz BA; Bieber CP; Jamieson SW; Raney AA; Oyer PE; Stinson EB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):390-2. PubMed ID: 7022859
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological properties of ciclosporin (Sandimmune).
    Borel JF
    Contrib Nephrol; 1986; 51():10-8. PubMed ID: 3568663
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings of the Second International Congress on Cyclosporine. November 4-7, 1987, Washington, DC. I. Nature of the agent and its immunologic actions.
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):1-734. PubMed ID: 3363636
    [No Abstract]   [Full Text] [Related]  

  • 31. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporine immunosuppression in organ graft recipients: nursing implications.
    Montefusco CM; Goldsmith J; Veith FJ
    Crit Care Nurse; 1984; 4(2):117-9. PubMed ID: 6561989
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporin-A-induced long-term survival of fully incompatible skin and heart grafts in rats.
    White DJ; Rolles K; Ottawa T; Turell O
    Transplant Proc; 1980 Jun; 12(2):261-5. PubMed ID: 6994294
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of action: ciclosporin- and prolactin-mediated control of immunity.
    Hiestand PC; Mekler P
    Prog Allergy; 1986; 38():239-46. PubMed ID: 3014546
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphapheresis in organ transplantation: preliminary report.
    Iwatsuki S; Iwaki Y; Klintmalm G; Kano T; Krams AK; Starzl TE
    Prog Clin Biol Res; 1982; 88():219-26. PubMed ID: 7048327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approaches for immunosuppression.
    Eiseman B; Hansbrough J; Weil R
    Am Surg; 1980 Jan; 46(1):24-7. PubMed ID: 6987927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Suppression of transplantation immunity under the action of hyperbaric oxygenation].
    Bokeriia LA; Kostava VT; Khurges ISh; Frolova MA
    Anesteziol Reanimatol; 1980; (5):67-9. PubMed ID: 7001957
    [No Abstract]   [Full Text] [Related]  

  • 38. Future directions in immunosuppression.
    Beckebaum S; Cicinnati VR; Broelsch CE
    Transplant Proc; 2004 Mar; 36(2 Suppl):574S-576S. PubMed ID: 15041408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between phenytoin and cyclosporine following organ transplantation.
    Keown PA; Laupacis A; Carruthers G; Stawecki M; Koegler J; McKenzie FN; Wall W; Stiller CR
    Transplantation; 1984 Sep; 38(3):304-6. PubMed ID: 6474556
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine: the base for immunosuppressive therapy--present and future.
    Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):508-10. PubMed ID: 7679819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.